|
Managing Director
Christopher Somogyi has over 27 years experience in the commercialization of innovation.
Venture Capital - As a partner with Tokyo-based Pacific Rim Ventures, Mr.
Somogyi invested in numerous companies in the US and Europe, in areas including proteomics, drug discovery, biotech services,
advanced diagnostic instrumentation, genomics, and diagnostic services. With CommTech Management, he invested in technologies
developed at Stanford, UC Irvine, and SRI International through a grant-seeding technology elicitation program.
Entrepreneur- As a co-founder of Lucent Medical Systems, he brought a University of Washington
technology from the research labs to a new commercial entity. As founder of Dentigenix, he assembled researchers from around
the world to advance tissue engineering within dental applications. As co-founder and Chairman of Ratner Biomedical Group,
he launched the first incubator for biomaterials and regenerative medicine new companies. As co-founder and Chairman
of Healionics, he is helping lead this new company to introduce novel biomaterials which heal. As co-founder and Chairman
of Calcionics, he is overseeing the team to develop a drugs to control the calcification of blood vessels. As co-founder
and Chairman of Inson, he is helping the effort to introduce novel ultrasonically-controllable drug delivery polymer systems.
As co-founder and Chairman of MotionBack, he is working with a world class team to bring kinematically correct compliant mechanism
designs to orthopedic devices such as total disk replacements. As co-founder and CEO of Advanced Electroluminescent
Sciences, he brought together researchers and essential intellectual property from around the world to develop low-cost solid
state lighting devices based on organic LED technology.
Executive-
As President and CEO of Lucent Medical Systems, he built the start-up from initiation through three rounds of venture capital
and two strategic corporate partnerships with Abbott and Becton Dickinson. As CEO and Chairman of Dentigenix, he led the tissue
engineering start-up through to acquisition by Europe's leading dental company.
Board
Leadership - Current corporate board memberships include: Ultreo, Inc., ScaleOut Software, Inc., Lucent Medical Systems, Healionics, Inc., Calcionics, Inc., Inson, Inc., Ratner Biomedical Group, and Motion Back. He also holds Advisory Board roles with several start up companies.
Engineer - Hands on experience in medical device new product development with American Hospital
and Puritan Bennett. Inventor for 8 issued US patents.
Technology Licensing
- With Stanford University's Office of Technology Licensing, Managed Stanford's portfolio of software and
medical device inventions. Negotiated technology licenses and managed technology transfer relationships with univeristies,
private research institues, and government research laboratories in the U.S.A., Canada, Taiwan, Finland, Germany, Netherlands,
France, Japan, Singapore, and New Zealand.
Angel Investor - A former
member of the Executive Committee of Seattle's Alliance of Angels, he has, through Somogyi Ventures, made dozens
of investments in early stage technology companies across North America.
Community
Contributor - He is a former member of the Board of the Technology Alliance, of the Executive Committee of
Seattle's Alliance of Angels, of the University of Washington's Business School Center for Innovation and Entrepreneurship,
of the University of Washington's Technology Transfer Advisory Board, and of the Nanophotonics Initiative Committee.
Mr. Somogyi is founder and primary supporter of the UW Bioengineering Summer Camp for High Schoolers.
Mr. Somogyi
holds a BSE in bioengineering from Purdue University, an MS in bioengineering from Tulane University, and an MBA from the
University of Washington.
Intellectual Property • Bioengineering • Regenerative
Medicine • Product Development • Material Science • Leverage • Market Share Battlegrounds
|
|